| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antitumor action and immune activation through cooperation of bee venom secretory phospholipase A2 and phosphatidylinositol-(3,4)-bisphosphate
|
Putz, Thomas
|
|
2006
|
55 |
11 |
p. 1374-1383
|
article
|
| 2 |
A recombinant PSMA-specific single-chain immunotoxin has potent and selective toxicity against prostate cancer cells
|
Wolf, P.
|
|
2006
|
55 |
11 |
p. 1367-1373
|
article
|
| 3 |
Autologous control of a highly malignant syngeneic CRNK-16 leukemia in the rat: a role for NK cells
|
Avraham, Roi
|
|
2006
|
55 |
11 |
p. 1348-1357
|
article
|
| 4 |
Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12
|
Kim, Chang-Hyun
|
|
2006
|
55 |
11 |
p. 1309-1319
|
article
|
| 5 |
Expression of macrophage-derived chemokine (MDC)/CCL22 in human lung cancer
|
Nakanishi, Toru
|
|
2006
|
55 |
11 |
p. 1320-1329
|
article
|
| 6 |
Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells
|
Chiang, Cheryl L.-L.
|
|
2006
|
55 |
11 |
p. 1384-1395
|
article
|
| 7 |
Immune enhancement and anti-tumour activity of IL-23
|
Hao, Jing-Sheng
|
|
2006
|
55 |
11 |
p. 1426-1431
|
article
|
| 8 |
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells
|
Kyte, Jon A.
|
|
2006
|
55 |
11 |
p. 1432-1442
|
article
|
| 9 |
Immunomodulatory impact of interferon-alpha in combination with chemoradiation of pancreatic adenocarcinoma (CapRI)
|
Schmidt, Jan
|
|
2006
|
55 |
11 |
p. 1396-1405
|
article
|
| 10 |
Interleukin 2 regulation following semi-allogeneic bone marrow transplantation in mice
|
Abdul-Hai, Ali
|
|
2006
|
55 |
11 |
p. 1330-1336
|
article
|
| 11 |
International Society for Cell and Gene Therapy of Cancer (ISCGT) annual meeting: conference overview and introduction to the symposium papers
|
Guinn, Barbara-ann
|
|
2006
|
55 |
11 |
p. 1406-1411
|
article
|
| 12 |
Non-viral in vivo immune gene therapy of cancer: combined strategies for treatment of systemic disease
|
Tangney, M.
|
|
2006
|
55 |
11 |
p. 1443-1450
|
article
|
| 13 |
PankoMab: a potent new generation anti-tumour MUC1 antibody
|
Danielczyk, Antje
|
|
2006
|
55 |
11 |
p. 1337-1347
|
article
|
| 14 |
Substitution analog peptide derived from HER-2 can efficiently induce HER-2-specific, HLA-A24 restricted CTLs
|
Mimura, Kousaku
|
|
2006
|
55 |
11 |
p. 1358-1366
|
article
|
| 15 |
Targeted and shielded adenovectors for cancer therapy
|
Hedley, Susan J.
|
|
2006
|
55 |
11 |
p. 1412-1419
|
article
|
| 16 |
Tumour-expressed tissue factor inhibits cellular cytotoxicity
|
Li, Chao
|
|
2006
|
55 |
11 |
p. 1301-1308
|
article
|
| 17 |
Virology- and immunology-based gene therapy for cancer
|
Tagawa, Masatoshi
|
|
2006
|
55 |
11 |
p. 1420-1425
|
article
|
Journal description